80 results
Page 3 of 4
8-K
EX-1.1
7dhsba1wpa68x
6 May 21
Entry into a Material Definitive Agreement
5:10pm
424B5
giau6pkv
6 May 21
Prospectus supplement for primary offering
5:01pm
S-3ASR
wn28fgx7
6 May 21
Automatic shelf registration
4:33pm
S-3ASR
EX-4.2
hh6c0zhff 5v
6 May 21
Automatic shelf registration
4:33pm
DEF 14A
liq 8q7j5
26 Apr 21
Definitive proxy
6:05am
S-8
nde4x6zr32yd4n
23 Mar 21
Registration of securities for employees
4:50pm
10-K
oajuml5
23 Mar 21
Annual report
4:21pm
8-K
EX-99.2
xnkmgav93ll3zq5z8
11 Jan 21
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Milestones
6:36am
424B4
60yay1
13 Nov 20
Prospectus supplement with pricing info
5:21pm
S-1MEF
zqs67vusrlws to
13 Nov 20
Registration of additional securities for an S-1
6:05am
DRS
nyomwq 0qq60nmza
20 Jul 20
Draft registration statement
12:00am
10-Q
6gp1i ydvlski
20 May 20
Quarterly report
4:31pm
8-K
EX-3.2
tlxhkk4jcx9idal
28 Apr 20
ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
5:22pm
S-8
laxlwcqs
24 Apr 20
Registration of securities for employees
5:09pm
424B4
0m9f45497ol3dyct
24 Apr 20
Prospectus supplement with pricing info
5:04pm